Publications by authors named "Lars Frelin"

Claim this Profile
P
Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.
Cong Si Tran, Julia Kersten, Jingyi Yan, Marco Breinig, Thorben Huth, Lars Frelin

Gastroenterology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.
Jingyi Yan, Chandrashekar Ravenna Bangalore, Negin Nikouyan, Sofia Appelberg, Daniela Nacimento Silva, Lars Frelin

Mol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Rani Burm, Panagiota Maravelia, Gustaf Ahlen, Sandra Ciesek, Noelia Caro Perez, Lars Frelin

Gut· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells.
Sofia Appelberg, Gustaf Ahlén, Jingyi Yan, Negin Nikouyan, Sofie Weber, Lars Frelin

EMBO Mol Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.
John Tyler Sandberg, Renata Varnaitė, Wanda Christ, Puran Chen, Jagadeeswara R Muvva, Lars Frelin

Clin Transl Immunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections.
Panagiota Maravelia, Lars Frelin, Yi Ni, Noelia Caro Pérez, Gustaf Ahlén

J Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Renata Varnaitė, Marina García, Hedvig Glans, Kimia T Maleki, John Tyler Sandberg, Lars Frelin

J Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.
Gustaf Ahlén, Lars Frelin, Negin Nikouyan, Friedemann Weber, Urban Höglund

J Virol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model.
Sepideh Levander, Fredrik Holmström, Lars Frelin, Gustaf Ahlén, Daniel Rupp

Gut· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neonatal Exposure to Hepatitis C Virus Antigens in Uninfected Children Born to Infected Mothers.
Afrodite Psaros Einberg, Erwin Daniel Brenndörfer, Lars Frelin, Lena Hallberg, Matti Sällberg

J Pediatr Gastroenterol Nutr· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of Association Between Interleukin 28B Polymorphism and Vertical Transmission of Hepatitis C.
Afrodite Psaros Einberg, Ann-Sofi Duberg, Olga Filipovich, Jessica Nyström, Anton Zhirkov, Lars Frelin

J Pediatr Gastroenterol Nutr· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties.
Anangi Balasiddaiah, Haleh Davanian, Soo Aleman, Anna Pasetto, Lars Frelin

J Virol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods to Evaluate Novel Hepatitis C Virus Vaccines.
Gustaf Ahlén, Lars Frelin

Methods Mol Biol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo.
Ruchi Bansal, Lars Frelin, Erwin Daniel Brenndörfer, Gert Storm, Jai Prakash

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospects and progress of DNA vaccines for treating hepatitis B.
Margaret Chen, Neetu Jagya, Ruchi Bansal, Lars Frelin, Matti Sällberg

Expert Rev Vaccines· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
Sepideh Levander, Matti Sällberg, Gustaf Ahlén, Lars Frelin

Vaccine· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses.
Fredrik Holmström, Margaret Chen, Anangi Balasiddaiah, Matti Sällberg, Gustaf Ahlén, Lars Frelin

Sci Rep· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A targeted controlled force injection of genetic material in vivo.
Gustaf Ahlén, Lars Frelin, Fredrik Holmström, Grant Smetham, Steve Augustyn

Mol Ther Methods Clin Dev· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccination.
Anette Brass, Lars Frelin, David R Milich, Matti Sällberg, Gustaf Ahlén

Mol Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electroporation for therapeutic DNA vaccination in patients.
Matti Sällberg, Lars Frelin, Gustaf Ahlén, Margaret Sällberg-Chen

Med Microbiol Immunol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Containing "The Great Houdini" of viruses: combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C.
Gustaf Ahlén, Lars Frelin, Erwin Daniel Brenndörfer, Anette Brass, Ola Weiland

Drug Resist Updat· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.
Ola Weiland, Gustaf Ahlén, Helmut Diepolder, Maria-Christina Jung, Sepideh Levander, Lars Frelin

Mol Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.
Anne Fournillier, Lars Frelin, Emilie Jacquier, Gustaf Ahlén, Anette Brass

J Infect Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients.
Nogol Rahbin, Lars Frelin, Soo Aleman, Rolf Hultcrantz, Matti Sällberg

Biochem Biophys Res Commun· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice.
Fredrik Holmström, Anna Pasetto, Veronica Nähr, Anette Brass, Malte Kriegs, Lars Frelin

J Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis